Lithium shows hope for Alzheimer’s disease

According to scientists Alzheimer’s disease, a progressively damaging motor neuron condition, could be treated by lithium, a naturally occurring element that is extremely inexpensive and already in use for other psychiatric disorders.

Lithium has been in use to treat mood swings and bipolar disorder and now, researchers at Sao Paulo University in Brazil, led by Dr Orestes Forlenza have discovered that the pills slowed down memory loss in the elderly, reducing their cognitive decline. They also noted that there was a decrease in build-up of tangles of damaging proteins called phospho- tau in people's brain fluid which characterized Alzheimer's disease.

For the study the team examined 41 people over the age of 60 with mild cognitive impairment, out of whom 21 took low doses of lithium every day for a year. All went through tests of memory and attention and a sample of their brain fluid was analyzed for tau concentrations. Although all the participants showed a decline in memory function over the year, those taking lithium showed less of a decline than those taking the placebo. Those taking lithium also had less of a form of the tau protein, pTau – a hallmark of Alzheimer’s disease – in their cerebrospinal fluid. The findings are published today in the British Journal of Psychiatry. The researchers now want to see larger studies to investigate whether lithium could have potential as a preventative treatment for Alzheimer’s.

Dr Orestes Forlenza, who led the research, said, “This study supports the idea that giving lithium to a person who is at risk of Alzheimer’s disease may have a protective effect, and slow down the progression of memory loss to dementia.”

Rebecca Wood, Chief Executive of Alzheimer’s Research UK, said, “Although these are encouraging results, this was a small study, and it is too soon to draw any firm conclusions from these findings. We need to see much larger, long-term studies carried out before we can know whether lithium could help prevent Alzheimer’s…There are currently 820,000 people affected by dementia, yet research is desperately underfunded. We must invest in more research if we are to find an effective treatment that is so urgently needed.”

Professor Allan Young, a psychiatrist from Imperial College London, described the study as “encouraging” - and particularly interesting because no pharmaceutical company has a patent on lithium, meaning it is very cheap to prescribe. He added, “This trial adds to the increasing evidence that lithium may have beneficial effects on the brain and begs to be replicated in further randomised trials.” Dr Anne Corbett, research manager at the Alzheimer's Society, added, “We need more, larger clinical trials to test existing drugs like lithium if we are to find better treatments for people with Alzheimer’s. Yet such trials are very expensive. We need greater investment in this area in order to help us develop better treatments for people with this devastating condition.”

Dr. Ananya Mandal

Written by

Dr. Ananya Mandal

Dr. Ananya Mandal is a doctor by profession, lecturer by vocation and a medical writer by passion. She specialized in Clinical Pharmacology after her bachelor's (MBBS). For her, health communication is not just writing complicated reviews for professionals but making medical knowledge understandable and available to the general public as well.


Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Mandal, Ananya. (2020, April 03). Lithium shows hope for Alzheimer’s disease. News-Medical. Retrieved on February 04, 2023 from

  • MLA

    Mandal, Ananya. "Lithium shows hope for Alzheimer’s disease". News-Medical. 04 February 2023. <>.

  • Chicago

    Mandal, Ananya. "Lithium shows hope for Alzheimer’s disease". News-Medical. (accessed February 04, 2023).

  • Harvard

    Mandal, Ananya. 2020. Lithium shows hope for Alzheimer’s disease. News-Medical, viewed 04 February 2023,


  1. psychicviking Atwell psychicviking Atwell United States says:

    Lithium succinate is known to prevent the replication of herpes simplex virus. So there is a chance lithium prevents the replication of other viruses  and other pathogens. So lithium preventing Alzheimers might be connected to this action/these actions.

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
You might also like...
People with poor oral health may be more likely to show signs of declining brain health